肿瘤免疫治疗中PD—1/PD—L1抑制剂的研究进展(5)
[23] Muro K，Chung HC，Shankaran V，et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012)：a multicentre， open-label， phase 1b trial [J]. Lancet Oncol ......
您现在查看是摘要页，全文长 1510 字符。